{"id":761,"date":"1999-07-01T12:01:00","date_gmt":"1999-07-01T10:01:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/unerwuenschte-wirkungen-von-zytostatika"},"modified":"2022-03-17T14:09:12","modified_gmt":"2022-03-17T13:09:12","slug":"unerwuenschte-wirkungen-von-zytostatika","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/unerwuenschte-wirkungen-von-zytostatika","title":{"rendered":"Unerw\u00fcnschte Wirkungen von Zytostatika"},"content":{"rendered":"<p>(Fortsetzung unseres Hauptartikels AMB 1999, 33, 41) Tabelle 2C Sp\u00e4tsch\u00e4den von Zytostatika (Monate bis Jahre nach Applikation)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Fortsetzung unseres Hauptartikels AMB 1999, 33, 41) Tabelle 2C Sp\u00e4tsch\u00e4den von Zytostatika (Monate bis Jahre nach Applikation)<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[189,268,1964,1967,1966,704,33,1965,701,271,705,30,188,27,457,700,1963,1962,274,703,699,706,702,392,393,270,39,707,710,1144,1968,286,276,708,279,280,709,1969,1959,1957,1961,1960,698,740,365,696,1958,265,697,262,264],"class_list":["post-761","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-2-chlordesoxyadenosin","tag-5-fluorouracil","tag-alkylanzien","tag-anthrazykline","tag-bendamustin","tag-bleomycin","tag-busulfan","tag-carboplatin","tag-carmustin","tag-chemotherapie","tag-chlorambucil","tag-cisplatin","tag-cladribin","tag-cyclophosphamid","tag-cytarabin","tag-dacarbazin","tag-dactinomycin","tag-daunorubicin","tag-docetaxel","tag-doxorubicin","tag-emesis","tag-epirubicin","tag-erbrechen","tag-etoposid","tag-fludarabin","tag-gemcitabin","tag-hydroxycarbamid","tag-idarubicin","tag-ifosfamid","tag-irinotecan","tag-lomustin","tag-melphalan","tag-methotrexat","tag-mitomycin","tag-mitoxantron","tag-paclitaxel","tag-procarbacin","tag-procarbazin","tag-purin-analoga","tag-pyrimidin-analoga","tag-taxane","tag-teniposid","tag-thioguanin","tag-thiotepa","tag-topotecan","tag-vinblastin","tag-vinca-alkaloide","tag-vincristin","tag-vinorelbin","tag-zytostatika","tag-zytostatische-therapie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=761"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/761\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}